Try a single issue or save on a subscription Issues delivered straight to your door or device ...

Awareness of sleep apnea and its relatively common and effective treatment has grown over the past three decades.

Leerink Partners analyst Mike Kratky has maintained their neutral stance on INSP stock, giving a Hold rating on January 13.Stay Ahead of the ...

Obstructive Sleep Apnea affects 1 in 15 Americans, likely more, and treatment has often involved inconvenient treatments like CPAP machines. A new device called Inspire offers new alternatives for ...

You don’t realize that you could be sleeping for eight hours but when you get tested you actually only slept for one or two.” ...

There is a need for convenient methods for detecting apnea ... individualized treatment. Lisa Strauss, PhD, is a clinical psychologist in the Boston area. She specializes in sleep disorders.

The Centers for Medicare & Medicaid Services confirmed to CNBC that Medicare drug plans can now cover Eli Lilly’s (LLY) obesity drug ...

and PDMA-approved neurostimulation technology of its kind that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. For additional information about Inspire ...